Substance / Medication

Hypromellose

Overview

Active Ingredient
hypromellose
RxNorm CUI
27334

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

No related conditions have been mapped yet. Condition-intervention linkages are derived from SNOMED CT relationships and will expand as the knowledge graph grows.

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Decreased inflammatory biomarkers after using artificial tears withand hypromellose for dry eye.
Rodriguez-Pomar Candela, Carpena-Torres Carlos, Serramito Maria et al. · Clin Exp Optom · 2025
PMID: 40258777RCT
Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye.
Capita Leonardo, Chalita Maria R, dos Santos-Neto Leopoldo Luiz · Cornea · 2015
PMID: 25514700RCT
Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
Ghori Muhammad U, Ginting Gidion, Smith Alan M et al. · Int J Pharm · 2014
PMID: 24560637Observational
A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
Birchall J C, Jones B E, Morrissey A et al. · Drug Dev Ind Pharm · 2008
PMID: 18686093Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Hypromellose (substance)
SNOMED CT
412410003
UMLS CUI
C0063242
RxNorm CUI
27334

Clinical Data

This intervention maps to 0 entities in the Ltrl knowledge graph.

0
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.